Literature DB >> 10970775

Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines, but does not prevent cardiac hypertrophy.

C A Mackintosh1, D J Feith, L M Shantz, A E Pegg.   

Abstract

Two lines of transgenic mice were produced with constitutive expression of antizyme-1 in the heart, driven from the cardiac alpha-myosin heavy chain promoter. The use of engineered antizyme cDNA in which nucleotide 205 had been deleted eliminated the need for polyamine-mediated frameshifting, normally necessary for translation of antizyme mRNA, and thus ensured the constitutive expression of antizyme. Antizyme-1 is thought to be a major factor in regulating cellular polyamine content, acting both to inhibit ornithine decarboxylase (ODC) activity and to target it for degradation, as well as preventing polyamine uptake. The two transgenic lines had substantial, but different, levels of antizyme in the heart, as detected by Western blotting and by the ability of heart extracts to inhibit exogenous purified ODC. Despite the high levels of antizyme, endogenous ODC activity was not completely abolished, with 10-39% remaining, depending on the transgenic line. Additionally, a relatively small decrease (30-32%) in cardiac spermidine content was observed, with levels of putrescine and spermine unaffected. Interestingly, although the two lines of transgenic mice had different antizyme expression levels, they had almost identical cardiac polyamine content. When treated with a single acute dose of isoprenaline (isoproterenol), cardiac ODC activity and putrescine content were substantially increased (by 14-fold and 4.7-fold respectively) in non-transgenic littermate mice, but these increases were completely prevented in the transgenic mice from both founder lines. Prolonged exposure to isoprenaline also caused increases in cardiac ODC activity and polyamine content, as well as an increase in cardiac growth, in non-transgenic mice. Although the increases in cardiac ODC activity and polyamine content were prevented in the transgenic mice from both founder lines, the increase in cardiac growth was unaffected. These transgenic mice thus provide a valuable model system in which to study the importance of polyamine levels in cardiac growth and electrophysiology in response to stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970775      PMCID: PMC1221293     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

1.  Polyamine-mediated heart hypertrophy induced by clenbuterol in the mouse.

Authors:  J C Cubría; R Reguera; R Balaña-Fouce; C Ordóñez; D Ordóñez
Journal:  J Pharm Pharmacol       Date:  1998-01       Impact factor: 3.765

2.  Assay of mammalian ornithine decarboxylase activity using [14C]ornithine.

Authors:  C S Coleman; A E Pegg
Journal:  Methods Mol Biol       Date:  1998

3.  Identification of regulatory region of antizyme necessary for the negative regulation of polyamine transport.

Authors:  K Sakata; T Fukuchi-Shimogori; K Kashiwagi; K Igarashi
Journal:  Biochem Biophys Res Commun       Date:  1997-09-18       Impact factor: 3.575

Review 4.  Interactions of polyamines with ion channels.

Authors:  K Williams
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

5.  Osmotic stress induces variation in cellular levels of ornithine decarboxylase-antizyme.

Authors:  J L Mitchell; G G Judd; A Leyser; C Choe
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

Review 6.  Inward rectifier potassium channels.

Authors:  C G Nichols; A N Lopatin
Journal:  Annu Rev Physiol       Date:  1997       Impact factor: 19.318

7.  A second mammalian antizyme: conservation of programmed ribosomal frameshifting.

Authors:  I P Ivanov; R F Gesteland; J F Atkins
Journal:  Genomics       Date:  1998-09-01       Impact factor: 5.736

8.  Activity-dependent modulation of glutamate receptors by polyamines.

Authors:  D Bowie; G D Lange; M L Mayer
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

9.  Inhibition of vacuolar ion channels by polyamines.

Authors:  O R Dobrovinskaya; J Muñiz; I I Pottosin
Journal:  J Membr Biol       Date:  1999-01-15       Impact factor: 1.843

10.  Blockade of a retinal cGMP-gated channel by polyamines.

Authors:  Z Lu; L Ding
Journal:  J Gen Physiol       Date:  1999-01       Impact factor: 4.086

View more
  5 in total

1.  Different intracellular polyamine concentrations underlie the difference in the inward rectifier K(+) currents in atria and ventricles of the guinea-pig heart.

Authors:  Ding-Hong Yan; Kazuhiro Nishimura; Kaori Yoshida; Kei Nakahira; Tsuguhisa Ehara; Kazuei Igarashi; Keiko Ishihara
Journal:  J Physiol       Date:  2005-01-24       Impact factor: 5.182

2.  Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy.

Authors:  L M Shantz; D J Feith; A E Pegg
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

3.  Effect of O6-alkylguanine-DNA alkyltransferase on genotoxicity of epihalohydrins.

Authors:  Aley G Kalapila; Natalia A Loktionova; Anthony E Pegg
Journal:  Environ Mol Mutagen       Date:  2009-07       Impact factor: 3.216

4.  Hepatic fibrogenesis requires sympathetic neurotransmitters.

Authors:  J A Oben; T Roskams; S Yang; H Lin; N Sinelli; M Torbenson; U Smedh; T H Moran; Z Li; J Huang; S A Thomas; A M Diehl
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

5.  Alkyltransferase-mediated toxicity of 1,3-butadiene diepoxide.

Authors:  Aley G Kalapila; Natalia A Loktionova; Anthony E Pegg
Journal:  Chem Res Toxicol       Date:  2008-08-20       Impact factor: 3.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.